Granulomatosis with Polyangiitis (GPA): Causes, Risk Factors & Pathogenesis

Overview

GPA (formerly Wegener's granulomatosis) is an ANCA-associated vasculitis (AAV) affecting small-to-medium vessels, with necrotizing granulomatous inflammation.

Etiology: Multifactorial

No single cause. Interaction of genetic susceptibility + environmental triggers → loss of tolerance → autoimmunity.

Genetic Factors

  • HLA-DPB1*0401 – strongest association.
  • SERPINA1 (α1-antitrypsin) variants.
  • PTPN22, CTLA4, FCGR2A – immune regulation genes.
  • Family clustering rare but reported; heritability estimated ~30%.

Environmental Triggers

TriggerEvidence
Silica DustOccupational exposure (mining, sandblasting, construction) – dose-dependent risk (OR 2–5).
InfectionsS. aureus nasal carriage (chronic) linked to relapse; S. pneumoniae, viral triggers reported.
MedicationsPropylthiouracil, hydralazine, minocycline, allopurinol – can induce ANCA+ vasculitis (drug-induced AAV).
SmokingStrong risk factor for PR3-ANCA+ GPA; also worsens lung outcomes.

Pathogenic Sequence (Simplified)

  1. Genetic risk + trigger → neutrophil priming.
  2. PR3/MPO expressed on surface → ANCA binding.
  3. ANCA-activated neutrophils → ROS, proteases, NETs → endothelial damage.
  4. Granuloma formation (T-cell driven) in respiratory tract/kidneys.
  5. Vasculitic vessel necrosis → organ ischemia.

Clinical Phenotypes

  • PR3-ANCA (c-ANCA): Classic GPA – upper/lower respiratory + renal.
  • MPO-ANCA (p-ANCA): More renal-limited, less granulomatous.

Implication

Risk factor modification (smoking cessation, silica avoidance) may reduce onset/relapse. Early ANCA monitoring in high-risk exposures is not standard but under study.

Tumors - Related Articles